Kilitch Drugs (India) Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 412.02 million compared to INR 306.97 million a year ago. Revenue was INR 416.91 million compared to INR 309.37 million a year ago. Net income was INR 47.41 million compared to INR 24.28 million a year ago. Basic earnings per share from continuing operations was INR 2.93 compared to INR 1.56 a year ago. Diluted earnings per share from continuing operations was INR 2.93 compared to INR 1.56 a year ago.
For the six months, sales was INR 777.59 million compared to INR 641.5 million a year ago. Revenue was INR 788.11 million compared to INR 653.61 million a year ago. Net income was INR 80.98 million compared to INR 45.14 million a year ago. Basic earnings per share from continuing operations was INR 5.08 compared to INR 2.9 a year ago. Diluted earnings per share from continuing operations was INR 5.08 compared to INR 2.9 a year ago.